SNT
Syntara
Pharmaceuticals, Biotechnology & Life Sciences
Syntara Limited is a clinical stage drug development company with a focus on blood-related cancers. The company¿¿¿s highly productive drug discovery engine is driven by its expertise in amine oxidase inhibitors.
Shorted
short percentage0.10%
reported shorts1.7M
shares on issue1.633B
About
website
industry
address
Key Metrics
market cap
$52.26Meps$-0.01
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Short Position Trends
Track bearish sentiment and short interest over time
Historical Price Data
View stock price movements, volume, and trading patterns